DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
72.83
-1.63 (-2.19%)
Nov 22, 2024, 4:00 PM EST - Market closed
DexCom Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for DexCom stock have an average target of 101.29, with a low estimate of 75 and a high estimate of 161. The average target predicts an increase of 39.08% from the current stock price of 72.83.
Analyst Consensus: Buy
* Price targets were last updated on Oct 25, 2024.
Analyst Ratings
The average analyst rating for DexCom stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 6 | 6 | 6 | 6 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 3 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Maintains $82 → $86 | Buy | Maintains | $82 → $86 | +18.08% | Oct 25, 2024 |
| Raymond James | Raymond James | Strong Buy Maintains $115 → $99 | Strong Buy | Maintains | $115 → $99 | +35.93% | Oct 25, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $120 → $115 | Buy | Maintains | $120 → $115 | +57.90% | Oct 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $115 → $105 | Buy | Maintains | $115 → $105 | +44.17% | Oct 25, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $75 → $85 | Hold | Maintains | $75 → $85 | +16.71% | Oct 25, 2024 |
Financial Forecast
Revenue This Year
4.10B
from 3.62B
Increased by 13.10%
Revenue Next Year
4.70B
from 4.10B
Increased by 14.82%
EPS This Year
1.74
from 1.30
Increased by 33.69%
EPS Next Year
2.07
from 1.74
Increased by 19.03%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.2B | 5.0B | 5.9B | ||
| Avg | 4.1B | 4.7B | 5.4B | ||
| Low | 3.9B | 4.4B | 4.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 16.9% | 21.2% | 25.7% | ||
| Avg | 13.1% | 14.8% | 15.5% | ||
| Low | 8.1% | 7.2% | 2.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.83 | 2.33 | 3.02 | ||
| Avg | 1.74 | 2.07 | 2.52 | ||
| Low | 1.62 | 1.85 | 2.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 40.3% | 33.7% | 45.9% | ||
| Avg | 33.7% | 19.0% | 21.6% | ||
| Low | 24.2% | 6.3% | 6.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.